|
⚲
|
| Keyboard |
| Marc Riiska | |
|---|---|
| Firm | Tuatara Capital LP |
| Address | 211 East 43rd Street 24th Floor New York City, NY 10017 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Tuatara Capital LP | |||||
| NYC CLF LP | 021-527049 | Executive Officer | 9.4 M of 30.0 M |
9.2 M | |
| TC CIP V LP | 021-413026 | Executive Officer | 5.6 M | ||
| TC CIP IV LP | 021-439892 | Executive Officer | 4.2 M of 4.2 M |
5.1 M | |
| Tuatara Capital Fund II LP | 021-331929 | Executive Officer | 267.5 M of 375.0 M |
68.2 M | |
| TC CIP III LP | 021-319209 | Executive Officer | 16.9 M of 16.9 M |
7.0 M | |
| TC CIP II LP | 021-298485 | Executive Officer | 5.2 M of 5.2 M |
3.1 M | |
| TC CIP I LP | 021-282557 | Executive Officer | 9.3 M of 9.3 M |
0.2 M | |
| Tuatara Capital Parallel Fund I LP | 021-269595 | Executive Officer | 46.4 M of 120.0 M |
21.1 M | |
| Tuatara Capital Fund I LP | 021-244878 | Executive Officer | 37.1 M | 21.5 M | |
| Long Play Inc | 021-516014 | Director | 0.5 M of 0.5 M |
||
| Long Play Inc | 021-509015 | Director | 0.2 M of 0.2 M |
||
| Long Play Inc | 021-501568 | Director | 0.2 M of 0.2 M |
||
| Long Play Inc | 021-428265 | Director | 5.0 M of 20.0 M |
||
| Long Play Inc | 021-396732 | Director | 114.7 M of 114.7 M |
||
| Front Range Biosciences Inc | 021-360645 | Director | 18.7 M of 40.3 M |
||
| Demetrix Inc | 021-344040 | Director | 50.0 M of 50.5 M |
||
| Eyechronic LLC | 021-339055 | Director | 1.0 M of 6.6 M |
||